{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:17:31Z","timestamp":1648923451008},"reference-count":10,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":6865,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Acta Neuropsychiatr."],"published-print":{"date-parts":[[1996,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The research on anxiety disorders of the department of psychiatry of the Vrije Universiteit is briefly reviewed. Studies have included comparisons between pharmacotherapy and cognitive behaviour therapy and combination treatments of panic disorder and of obsessive-compulsive disorder. Also, the hyperventilation model of panic disorder could be rejected as a result of an ambulatory monitoring study. Provocation studies with adrenalin in panic disorder have shown less support for a psychological model of panic than expected. Recommendations for future research include studies on anxiety in the very young and in the elderly, studies on comorbidity in anxiety, especially with alcoholism and depression and the development of treatment manuals for general practice. The issue is raised whether investing in neuroimaging studies will critically advance our knowledge in the near future.<\/jats:p>","DOI":"10.1017\/s0924270800037005","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T01:19:02Z","timestamp":1469495942000},"page":"96-98","update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Psychological and biological aspects of anxiety disorders"],"prefix":"10.1017","volume":"8","author":[{"given":"R.","family":"van Dyck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"S0924270800037005_ref009","volume-title":"Fear of bodily sensations, epinephrine and panic attacks","author":"Veltman","year":"1995"},{"key":"S0924270800037005_ref005","volume-title":"Obsessive compulsive disorder: issues in assessment and treatment","author":"Oppen","year":"1994"},{"key":"S0924270800037005_ref004","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/ajp.152.5.683","article-title":"Fluvoxamine, placebo, psychological panic management and exposure in vivo in panic disorder with agoraphobia","volume":"152","author":"Beurs","year":"1995","journal-title":"Am J Psychiat"},{"key":"S0924270800037005_ref003","volume-title":"Comparative treatment studies in panic disorder with agoraphobia and obsessive compulsive disorder","author":"Balkom","year":"1994"},{"key":"S0924270800037005_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(94)00052-L"},{"key":"S0924270800037005_ref002","volume-title":"The assessment and treatment of panic disorder and agoraphobia","author":"Beurs","year":"1992"},{"key":"S0924270800037005_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/0272-7358(92)90111-K"},{"key":"S0924270800037005_ref008","first-page":"513","article-title":"Hyperventilation and panic attacks","author":"Garssen","year":"1996","journal-title":"Am J Psychiat"},{"key":"S0924270800037005_ref010","volume-title":"The role of adrenalin in anxiety and anxiety disorders: a psychophysiological study","author":"Zijderveld","year":"1995"},{"key":"S0924270800037005_ref001","doi-asserted-by":"publisher","DOI":"10.1016\/0272-7358(94)90033-7"}],"container-title":["Acta Neuropsychiatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924270800037005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T15:49:37Z","timestamp":1557676177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924270800037005\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["S0924270800037005"],"URL":"https:\/\/doi.org\/10.1017\/s0924270800037005","relation":{},"ISSN":["0924-2708","1601-5215"],"issn-type":[{"value":"0924-2708","type":"print"},{"value":"1601-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]},"assertion":[{"value":"Copyright \u00a9 Scandinavian College of Neuropsychopharmacology 1996","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}